Stock OCTP OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Oxford Cannabinoid Technologies Holdings Plc

Equities

OCTP

GB00BMVMRB86

Biotechnology & Medical Research

Market Closed - London S.E.
Other stock markets
 11:35:18 2024-04-26 am EDT 		5-day change 1st Jan Change
0.365 GBX -1.35% Intraday chart for Oxford Cannabinoid Technologies Holdings Plc +8.96% -41.60%
Apr. 11 Oxford Cannabinoid teams with iNGENu to test OCT130401 pain treatment AN
Apr. 09 Oxford Cannabinoid Technologies Holdings plc Appoints Timothy Henry Corn as A Director CI

Valuation

Fiscal Period: April 2022 2023 2024 2025
Capitalization 1 11.28 13.73 3.973 -
Enterprise Value (EV) 1 11.28 11.44 2.788 6.001
P/E ratio -2.39 x - -1.66 x -1.26 x
Yield - - - -
Capitalization / Revenue - - - -
EV / Revenue - - - -
EV / EBITDA - -1.65 x -0.81 x -1.51 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book - - - -
Nbr of stocks (in thousands) 960,416 960,416 1,088,416 -
Reference price 2 0.0118 0.0143 0.003650 0.003650
Announcement Date 7/25/22 8/31/23 - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Abril 2022 2023 2024 2025
Net sales 1 - - - -
EBITDA 1 - -6.935 -3.438 -3.984
EBIT 1 - -7.038 -3.484 -3.984
Operating Margin - - - -
Earnings before Tax (EBT) 1 - -7.034 -3.475 -3.978
Net income 1 -4.712 -5.945 -2.2 -3.153
Net margin - - - -
EPS 2 -0.004910 - -0.002200 -0.002900
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share 2 - - - -
Announcement Date 7/25/22 8/31/23 - -
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: April 2022 2023 2024 2025
Net Debt 1 - - - 2.03
Net Cash position 1 - 2.3 1.19 -
Leverage (Debt/EBITDA) - - - -0.509 x
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - - - -
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share - - - -
Cash Flow per Share - - - -
Capex - - - -
Capex / Sales - - - -
Announcement Date 7/25/22 8/31/23 - -
1GBP in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC Stock Oxford Cannabinoid Technologies Holdings Plc
-41.60% 4.95M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. OCTP Stock
  4. Financials Oxford Cannabinoid Technologies Holdings Plc